Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
388 participants
INTERVENTIONAL
2021-09-20
2022-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Errors of Refraction Among Primary School Children
NCT05366543
Low Dose Atropine Eye Drops in Myopic Egyptian Children
NCT06265454
OCT-A and Amblyopia
NCT05223153
Prevalence of Refractive Errors in Primary School Children
NCT05781997
Cycloplegic Refraction in Pediatric Patients With Esotropia
NCT06077682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cycloplegic refraction
All refractions were measured before and after cycloplegic addition to the eye.
Cycloplegics
they are drugs that paralyze the ciliary muscles and cause relaxation of accommodation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cycloplegics
they are drugs that paralyze the ciliary muscles and cause relaxation of accommodation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal intra ocular pressure (IOP≤21 mmHg.
* Age \> 2 years and \< 10 years
Exclusion Criteria
* Previous ocular surgery
* Any diagnosed ocular disease
* History of ocular trauma
* Irregular astigmatism on corneal topography.
2 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ehab tharwat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ehab tharwat
Damietta, New Damietta, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cycloplegia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.